Aligos Therapeutics, Inc.
ALGS
$5.45
-$0.38-6.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -24.00% | -20.75% | -16.15% | -16.92% | 92.68% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.16% | -2.66% | -5.46% | -1.02% | 27.67% |
| Total Current Assets | -22.15% | -19.83% | -15.66% | -16.32% | 89.01% |
|
|
|||||
| Total Current Assets | -22.15% | -19.83% | -15.66% | -16.32% | 89.01% |
| Net Property, Plant & Equipment | -8.07% | -7.44% | -6.55% | -6.16% | -7.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.26% | 0.63% | 0.96% | 0.00% | 0.32% |
| Total Assets | -20.73% | -18.73% | -14.93% | -15.59% | 76.50% |
|
|
|||||
| Total Accounts Payable | -6.17% | -59.82% | 139.94% | 12.91% | -14.42% |
| Total Accrued Expenses | 9.86% | 17.38% | 0.17% | -28.49% | 36.68% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.71% | 1.34% | 2.47% | 1.08% | -0.49% |
| Total Finance Division Other Current Liabilities | -76.95% | -50.60% | 83.91% | -44.88% | -66.89% |
| Total Other Current Liabilities | -76.95% | -50.60% | 83.91% | -44.88% | -66.89% |
| Total Current Liabilities | 3.73% | -11.07% | 24.81% | -21.02% | 6.40% |
|
|
|||||
| Total Current Liabilities | 3.73% | -11.07% | 24.81% | -21.02% | 6.40% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.23% | -11.56% | -10.11% | -8.71% | -7.26% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 522.05% | 0.91% | -72.54% | 52.00% | 59,991.30% |
| Total Liabilities | 158.46% | -7.82% | -38.95% | 14.57% | 91.57% |
|
|
|||||
| Common Stock & APIC | 0.55% | 0.35% | 0.41% | 0.46% | 12.68% |
| Retained Earnings | -15.33% | -3.73% | 0.97% | -7.16% | -6.08% |
| Treasury Stock & Other | -21.84% | 16.80% | 3.78% | -12.66% | 9.66% |
| Total Common Equity | -157.83% | -25.48% | 12.43% | -35.06% | 67.96% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -157.83% | -25.48% | 12.43% | -35.06% | 67.96% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -157.83% | -25.48% | 12.43% | -35.06% | 67.96% |
|
|
|||||